Acceleron, Genomic Health among week’s notable insider transactions

Celgene purchased 706,206 shares OF Acceleron Pharma, Baker Bros. sold 208,831 shares of Genomic Health

NOTABLE INSIDER PURCHASES: Significant Insider purchases reported in the prior week from January 21 through January 25 include:

• Beneficial Owner of Acceleron Pharma (XLRN) Celgene (CELG) purchased 706,206 shares of company stock at $43 per share for a total transaction value of  $30,366,858
• Director and Beneficial Owner of   Bellerophon Therapeutics  (BLPH) Theodore Wang Purchased  450,000 shares of company stock at an average price of        70c per share for a total transaction value of  $315,000

NOTABLE INSIDER SALES: Significant Insider sales reported in the prior week from January 21 through January 25 include:

• Shareholder of Genomic Health (GHDX) Baker Bros. sold 208,831 shares of company stock at $71.86 for a total transaction value of $15,006,345
• Shareholder of MedEquities Realty Trust (MRT) BlueMountain Capital sold 362,699 of company stock at $10.94 per share for a total transaction value of $3,969,197

https://thefly.com/permalinks/entry.php/id2854629/RVI;XLRN;IDSY;BLPH;EGLE;GHDX;CSX;MRT;CBRL;QADA;CELG-Fly-Insider-Acceleron-Genomic-Health-among-weeks-notable-insider-transactions